UY30788A1 - CHEMICAL COMPOUNDS - Google Patents

CHEMICAL COMPOUNDS

Info

Publication number
UY30788A1
UY30788A1 UY30788A UY30788A UY30788A1 UY 30788 A1 UY30788 A1 UY 30788A1 UY 30788 A UY30788 A UY 30788A UY 30788 A UY30788 A UY 30788A UY 30788 A1 UY30788 A1 UY 30788A1
Authority
UY
Uruguay
Prior art keywords
chemical compounds
compound
formula
preparation
treatment
Prior art date
Application number
UY30788A
Other languages
Spanish (es)
Inventor
Andrew Aydon Godfrey
Boling Geng
Mark Cronin
Janelle Comita-Prevoir
Folkert Reck
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30788(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30788A1 publication Critical patent/UY30788A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

RESUMEN La presente invencion se refiere a compuesto de Formula (I) : o sales farmacéuticamente aceptables de los mismos, a su uso en el tratamiento de infecciones bacterianas, y a sus métodos de preparacionSUMMARY The present invention relates to a compound of Formula (I): or pharmaceutically acceptable salts thereof, its use in the treatment of bacterial infections, and its methods of preparation.

UY30788A 2006-12-15 2007-12-13 CHEMICAL COMPOUNDS UY30788A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30

Publications (1)

Publication Number Publication Date
UY30788A1 true UY30788A1 (en) 2008-07-31

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30788A UY30788A1 (en) 2006-12-15 2007-12-13 CHEMICAL COMPOUNDS

Country Status (17)

Country Link
EP (1) EP2121702A1 (en)
JP (1) JP2010513255A (en)
KR (1) KR20090090385A (en)
AR (1) AR064369A1 (en)
AU (1) AU2007331247B2 (en)
BR (1) BRPI0720236A2 (en)
CA (1) CA2671485A1 (en)
CL (1) CL2007003641A1 (en)
CO (1) CO6190619A2 (en)
EC (1) ECSP099506A (en)
MX (1) MX2009006325A (en)
NO (1) NO20092655L (en)
PE (1) PE20081511A1 (en)
RU (1) RU2009126731A (en)
TW (1) TW200831517A (en)
UY (1) UY30788A1 (en)
WO (1) WO2008071961A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (en) 2005-06-24 2014-01-29 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TWI436999B (en) 2008-10-10 2014-05-11 Actelion Pharmaceuticals Ltd Oxazolidinyl antibiotics
AR076222A1 (en) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2012045150A1 (en) * 2010-10-04 2012-04-12 British Columbia Cancer Agency Branch Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
CN117466803A (en) 2017-08-21 2024-01-30 阿卡蒂亚药品公司 Compounds, salts thereof and methods for treating diseases
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (en) * 1996-01-16 1997-07-17 Bayer Ag 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones
AR040336A1 (en) * 2002-06-26 2005-03-30 Glaxo Group Ltd PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND
JP5314244B2 (en) * 2004-10-27 2013-10-16 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (en) * 2005-06-24 2014-01-29 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
SG164384A1 (en) * 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
JP2009539807A (en) * 2006-06-09 2009-11-19 グラクソ グループ リミテッド Substituted 1-methyl-1H-quinolin-2-one and 1-methyl-1H-1,5-naphthyridin-2-one as antibacterial agents
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
PE20081551A1 (en) * 2006-07-20 2009-01-09 Glaxo Group Ltd QUINOLONE DERIVATIVES AS ANTIBACTERIALS

Also Published As

Publication number Publication date
AU2007331247A1 (en) 2008-06-19
WO2008071961A1 (en) 2008-06-19
ECSP099506A (en) 2009-08-28
AU2007331247B2 (en) 2011-10-20
CO6190619A2 (en) 2010-08-19
TW200831517A (en) 2008-08-01
NO20092655L (en) 2009-09-02
BRPI0720236A2 (en) 2013-12-24
WO2008071961A8 (en) 2009-10-22
PE20081511A1 (en) 2008-12-12
RU2009126731A (en) 2011-01-20
CA2671485A1 (en) 2008-06-19
CL2007003641A1 (en) 2008-09-22
JP2010513255A (en) 2010-04-30
MX2009006325A (en) 2009-07-24
KR20090090385A (en) 2009-08-25
AR064369A1 (en) 2009-04-01
EP2121702A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
UY30759A1 (en) CHEMICAL COMPOUNDS
ME01992B (en) Diarylhydantoin compounds
CR11861A (en) ORGANIC COMPOUNDS
EA201070786A1 (en) BENZOFUROPYRIMIDINONES
UY29170A1 (en) REPLACED ADENINS AND USES OF THE SAME
RS52534B (en) Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
UY32158A (en) HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME
UY30788A1 (en) CHEMICAL COMPOUNDS
TNSN08407A1 (en) Organic compounds
CY1109911T1 (en) PYRROLOVENZODIAZEPINES
DOP2010000259A (en) UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME-211
RS54123B1 (en) Therapeutic combination comprising dolutegravir, abacavir and lamivudine
EA200870193A1 (en) CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION
DOP2011000102A (en) FUSIONED ESPIROCICLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
ECSP088367A (en) DERIVATIVES OF BIFENYL AND ITS USE IN THE TREATMENT OF HEPATITIS C
DE602008000754D1 (en) TROPANVERBINDUNGEN
CY1114793T1 (en) Aminoprazole derivatives
UY30544A1 (en) PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
CR11859A (en) COMPOSITION AND PROCESS-356
UY31864A (en) DERIVATIVES OF UREA HETERICÍCLICA AND METHODS OF USE OF THE SAME-332
EA200801366A1 (en) DERIVATIVES 3,6-DIGIDRO-2-OXO-6N-1,3,4-TIADIAZINA
CO6382113A2 (en) CHEMICAL COMPOUNDS
UY32316A (en) USEFUL PIPERIDINE DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS
EA200900780A1 (en) EPOTHILON ANALOGUES MODIFIED IN C12-C13 PROVISIONS AS ANTICATIVE MEDICINES

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120611